After great feedback on our Biosimilars Intelligence Report, we have turned it into a weekly report that you can sign up to receive here: http://bit.ly/2nuuXMY The news is moving so quickly in the Biosimilars space. It’s 1) Global in nature 2)… →
NEWS On Gilead Sciences How Big of a Deal Are Gilead Sciences Patent Woes? The Motley Fool , 1 day ago A California District Court jury has found Gilead Sciences (NASDAQ:GILD) guilty of infringing upon patents co-owned by Merck & Co…. →
